News and Announcements
Credi’s Equity Crowdfund is LIVE!
- Published June 20, 2019 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Credi is excited to announce that their Equity Crowdfund is now live!
Credi is a loan management platform that formalises loans between friends and family. It’s an easy and affordable tool that removes the issues of lending between known parties and offers an alternative to the high interest rates of traditional lenders.
Investment Highlights
- Over 5,000 customers leading to $106+ million in loans from minimal marketing
- Significant investment to date has built a scalable end-to-end platform
- First mover advantage in a market worth $65 billion in Australia alone
- Distribution channels through partnerships including Longevity app and JUST ANNOUNCED ride share operator Oscar
Invest from as little at $210 and become part of the Credi journey.
About Credi
If you’ve ever loaned a friend or family member money, either personally or for their business you are officially a branch manager of “The bank of Mum and Dad”. You are also a part of one of fast growing sources of finance for the Australian economy.
Credi.com was born out of the pressing need to help establish and manage the growing number of these loans between family members, friends and businesses. ” Relationship lending is often at rates way below that offered by banks and other lenders ”
Company Updates
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Backed By Leading Investment Groups and Family Offices
